Bharat Biotech`s Covaxin effective against new COVID-19 variants, reveals study

A recent study has revealed that Bharat Biotech’s Covaxin produces neutralising titres against all new key variants of COVID-19 including the double mutant strain B.1.617 and B.1.1.7.

https://ift.tt/eA8V8J from https://ift.tt/3hqBUxO